Nu Skin Enterprises
Feb. 6, 2008
Page 5

Please note: This press release, particularly the “Outlook” section, contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that represent the company’s current expectations and beliefs, including, among other things: (i) management’s belief that it is in position to have a record year; (ii) that restructuring efforts are targeted to help the company achieve its objective of a 10.5 percent operating margin; (iii) the company’s estimates and expectations regarding tax-related adjustments with respect to prior periods; (iv) management’s revenue and earnings projections for the first quarter and for 2008 as well as its expectations for earnings growth set forth in the “Outlook” section. The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to: (a) risks that the company has not completed its review of its deferred tax assets and liabilities and that its estimates are preliminary and audit procedures have not been completed by its independent public accounting firm; (b) risks that reviews could result in additional adjustments or an increase in the amount of any identified adjustments from the amounts estimated for the past five years, and risks that the company may need to restate prior period financial statements if it determines such adjustments materially impact the current period or prior periods; (c) risks that could adversely impact the company’s operations or financial results in its markets, including its largest market, Japan, such as negative market conditions, foreign currency exchange rate fluctuations, material decreases in executive-level and active distributors, or the company’s failure to execute effective initiatives in these markets; (d) regulatory risks associated with the company’s products, including the Scanner, the Galvanic Spa^™ System II, and the ProDerm^™ Skin Analyzer, which could inhibit the use of these products in a market if they are determined to be medical devices in any market or if regulatory scrutiny dampens enthusiasm or the ability of the company or its distributors to effectively utilize them because of the restrictions on claims that can be made; (e) continued regulatory scrutiny and investigations in Mainland China, which have from time to time in the past, and could in the future, negatively impact the company’s business, including the interruption of sales activities in stores and the imposition of fines; (f) risks that the direct selling regulations in China are interpreted or enforced by governmental authorities in a manner that negatively impacts the company’s current or planned business model there, including continued delays and uncertainty in the provincial direct selling licensing process, and risk that the implementation of a direct selling model will not result in the anticipated growth of the company’s business in China given the restrictive nature of the direct selling laws; (g) any failure of current or planned initiatives or products to generate interest among distributors and customers and generate sponsoring and selling activities on a sustained basis; (h) any inability of the company to obtain necessary product registrations for its nutritional and personal care products in a timely manner, increased regulatory scrutiny of nutritional products by regulators or changes in regulatory requirements that impact our products; (i) any failure of the implementation of recent business transformation initiatives to reduce overhead and drive growth; (j) adverse publicity related to the company’s business, products, industry or any legal actions or complaints by distributors or others similar to claims made against some of the company’s competitors; (k) adverse results of tax audits and challenges by foreign tax authorities with respect to the amount of income tax, customs, duties and other amounts owed by the company; and (l) continued competitive pressures in the company’s markets. The company’s financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission, including the company’s Annual Report on Form 10-K filed on March 1, 2007 and Quarterly Report on Form 10-Q filed on November 9, 2007. The forward-looking statements set forth the company’s beliefs as of the date of this release, and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change.

-more-